Importantly, CD8+ T cells are induced to produce IFN-γ by DCs previously pulsed with sunitinib-treated sarcoma cells and this effect is significantly increased by PD-1 blocking with nivolumab. The gene discussed is IFNG; the disease is sarcoma.